Skip to main content
Fig. 4 | Translational Medicine Communications

Fig. 4

From: Preliminary report of a novel formulation of clinical-grade, fully matured, tumor-associated peptide-loaded dendritic cells for cancer immunotherapy

Fig. 4

Production of IL12p70. The DC activation marker, IL12p70, was measured by ELISA with or without CD40L stimulation. Histograms show the average IL12p70 level measured in the mDC medium in triplicate. For each peptide stimulation, a two-way t test (alpha = 0.05) was performed to compare the mean IL12p70 production in vehicle-treated versus CD40L-treated mDC (*, 0.01 < p < 0.05; **, p < 0.01; NS, not significant)

Back to article page

Translational Medicine Communications

ISSN: 2396-832X

Contact us